vs
Mirion Technologies, Inc.（MIR）与3M（MMM）财务数据对比。点击上方公司名可切换其他公司
3M的季度营收约是Mirion Technologies, Inc.的21.7倍（$6.0B vs $277.4M）。3M净利率更高（10.8% vs 6.2%，领先4.6%）。Mirion Technologies, Inc.同比增速更快（9.1% vs 1.3%）。3M自由现金流更多（$2.0B vs $63.2M）。过去两年Mirion Technologies, Inc.的营收复合增速更高（20.0% vs -1.8%）
Mirion Technologies是全球领先的辐射检测、监测与安全解决方案提供商，核心产品涵盖个人剂量测量系统、辐射成像设备及辐射风险管理软件，服务核电、医疗、国防、工业等多个核心领域，客户遍布北美、欧洲及亚太地区。
3M是美国知名跨国综合企业，业务覆盖工业、劳动者安全防护、消费品等多个领域，总部位于圣保罗郊区的枫木市。公司现有超6万款产品，涵盖胶粘剂、研磨材料、防火防护产品、个人防护装备、窗膜、车漆保护膜、电子连接绝缘材料、汽车养护产品、光学膜等品类。
MIR vs MMM — 直观对比
营收规模更大
MMM
是对方的21.7倍
$277.4M
营收增速更快
MIR
高出7.8%
1.3%
净利率更高
MMM
高出4.6%
6.2%
自由现金流更多
MMM
多$2.0B
$63.2M
两年增速更快
MIR
近两年复合增速
-1.8%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $277.4M | $6.0B |
| 净利润 | $17.3M | $653.0M |
| 毛利率 | 48.8% | 40.7% |
| 营业利润率 | 9.2% | 23.2% |
| 净利率 | 6.2% | 10.8% |
| 营收同比 | 9.1% | 1.3% |
| 净利润同比 | 15.3% | -41.5% |
| 每股收益（稀释后） | $0.07 | $1.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MIRMMM
| Q1 26 | — | $6.0B | ||
| Q4 25 | $277.4M | $6.1B | ||
| Q3 25 | $223.1M | $6.5B | ||
| Q2 25 | $222.9M | $6.3B | ||
| Q1 25 | $202.0M | $6.0B | ||
| Q4 24 | $254.3M | $6.0B | ||
| Q3 24 | $206.8M | $6.3B | ||
| Q2 24 | $207.1M | $6.3B |
净利润MIRMMM
| Q1 26 | — | $653.0M | ||
| Q4 25 | $17.3M | $577.0M | ||
| Q3 25 | $2.9M | $834.0M | ||
| Q2 25 | $8.3M | $723.0M | ||
| Q1 25 | $300.0K | $1.1B | ||
| Q4 24 | $15.0M | $728.0M | ||
| Q3 24 | $-13.6M | $1.4B | ||
| Q2 24 | $-11.7M | $1.1B |
毛利率MIRMMM
| Q1 26 | — | 40.7% | ||
| Q4 25 | 48.8% | 33.6% | ||
| Q3 25 | 46.8% | 41.8% | ||
| Q2 25 | 46.0% | 42.5% | ||
| Q1 25 | 47.6% | 41.6% | ||
| Q4 24 | 48.1% | 51.7% | ||
| Q3 24 | 44.9% | 42.1% | ||
| Q2 24 | 47.0% | 42.9% |
营业利润率MIRMMM
| Q1 26 | — | 23.2% | ||
| Q4 25 | 9.2% | 13.0% | ||
| Q3 25 | 3.3% | 22.2% | ||
| Q2 25 | 4.4% | 18.0% | ||
| Q1 25 | 4.3% | 20.9% | ||
| Q4 24 | 11.4% | 12.2% | ||
| Q3 24 | -0.8% | 20.9% | ||
| Q2 24 | 1.1% | 20.3% |
净利率MIRMMM
| Q1 26 | — | 10.8% | ||
| Q4 25 | 6.2% | 9.4% | ||
| Q3 25 | 1.3% | 12.8% | ||
| Q2 25 | 3.7% | 11.4% | ||
| Q1 25 | 0.1% | 18.7% | ||
| Q4 24 | 5.9% | 12.1% | ||
| Q3 24 | -6.6% | 21.8% | ||
| Q2 24 | -5.6% | 18.3% |
每股收益（稀释后）MIRMMM
| Q1 26 | — | $1.23 | ||
| Q4 25 | $0.07 | $1.07 | ||
| Q3 25 | $0.01 | $1.55 | ||
| Q2 25 | $0.03 | $1.34 | ||
| Q1 25 | $0.00 | $2.04 | ||
| Q4 24 | $0.08 | $1.33 | ||
| Q3 24 | $-0.07 | $2.48 | ||
| Q2 24 | $-0.06 | $2.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $412.3M | $3.7B |
| 总债务越低越好 | — | $10.9B |
| 股东权益账面价值 | $1.9B | $3.3B |
| 总资产 | $3.6B | $35.4B |
| 负债/权益比越低杠杆越低 | — | 3.29× |
8季度趋势，按日历期对齐
现金及短期投资MIRMMM
| Q1 26 | — | $3.7B | ||
| Q4 25 | $412.3M | — | ||
| Q3 25 | $933.2M | — | ||
| Q2 25 | $262.6M | — | ||
| Q1 25 | $185.8M | — | ||
| Q4 24 | $175.2M | — | ||
| Q3 24 | $133.3M | — | ||
| Q2 24 | $122.2M | — |
总债务MIRMMM
| Q1 26 | — | $10.9B | ||
| Q4 25 | — | $12.6B | ||
| Q3 25 | $444.8M | $12.6B | ||
| Q2 25 | $444.9M | $13.1B | ||
| Q1 25 | $686.6M | $13.5B | ||
| Q4 24 | $686.4M | $13.0B | ||
| Q3 24 | $685.1M | $13.2B | ||
| Q2 24 | $684.1M | $13.1B |
股东权益MIRMMM
| Q1 26 | — | $3.3B | ||
| Q4 25 | $1.9B | $4.7B | ||
| Q3 25 | $1.8B | $4.6B | ||
| Q2 25 | $1.5B | $4.3B | ||
| Q1 25 | $1.5B | $4.5B | ||
| Q4 24 | $1.5B | $3.8B | ||
| Q3 24 | $1.5B | $4.6B | ||
| Q2 24 | $1.5B | $3.9B |
总资产MIRMMM
| Q1 26 | — | $35.4B | ||
| Q4 25 | $3.6B | $37.7B | ||
| Q3 25 | $3.5B | $37.6B | ||
| Q2 25 | $2.7B | $38.0B | ||
| Q1 25 | $2.6B | $40.0B | ||
| Q4 24 | $2.6B | $39.9B | ||
| Q3 24 | $2.7B | $40.9B | ||
| Q2 24 | $2.6B | $43.4B |
负债/权益比MIRMMM
| Q1 26 | — | 3.29× | ||
| Q4 25 | — | 2.68× | ||
| Q3 25 | 0.24× | 2.72× | ||
| Q2 25 | 0.30× | 3.06× | ||
| Q1 25 | 0.46× | 3.02× | ||
| Q4 24 | 0.46× | 3.40× | ||
| Q3 24 | 0.45× | 2.84× | ||
| Q2 24 | 0.45× | 3.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.0M | — |
| 自由现金流经营现金流 - 资本支出 | $63.2M | $2.0B |
| 自由现金流率自由现金流/营收 | 22.8% | 33.6% |
| 资本支出强度资本支出/营收 | 3.5% | — |
| 现金转化率经营现金流/净利润 | 4.22× | — |
| 过去12个月自由现金流最近4个季度 | $106.9M | $3.7B |
8季度趋势，按日历期对齐
经营现金流MIRMMM
| Q1 26 | — | — | ||
| Q4 25 | $73.0M | $1.6B | ||
| Q3 25 | $22.3M | $1.8B | ||
| Q2 25 | $12.4M | $-954.0M | ||
| Q1 25 | $35.6M | $-79.0M | ||
| Q4 24 | $60.8M | $1.8B | ||
| Q3 24 | $17.1M | $-1.8B | ||
| Q2 24 | $15.2M | $1.0B |
自由现金流MIRMMM
| Q1 26 | — | $2.0B | ||
| Q4 25 | $63.2M | $1.3B | ||
| Q3 25 | $13.0M | $1.5B | ||
| Q2 25 | $3.6M | $-1.2B | ||
| Q1 25 | $27.1M | $-315.0M | ||
| Q4 24 | $49.1M | $1.5B | ||
| Q3 24 | $3.9M | $-2.0B | ||
| Q2 24 | $4.1M | $752.0M |
自由现金流率MIRMMM
| Q1 26 | — | 33.6% | ||
| Q4 25 | 22.8% | 21.8% | ||
| Q3 25 | 5.8% | 23.6% | ||
| Q2 25 | 1.6% | -18.3% | ||
| Q1 25 | 13.4% | -5.3% | ||
| Q4 24 | 19.3% | 25.4% | ||
| Q3 24 | 1.9% | -32.3% | ||
| Q2 24 | 2.0% | 12.0% |
资本支出强度MIRMMM
| Q1 26 | — | — | ||
| Q4 25 | 3.5% | 4.0% | ||
| Q3 25 | 4.2% | 3.3% | ||
| Q2 25 | 3.9% | 3.3% | ||
| Q1 25 | 4.2% | 4.0% | ||
| Q4 24 | 4.6% | 4.8% | ||
| Q3 24 | 6.4% | 3.9% | ||
| Q2 24 | 5.4% | 4.3% |
现金转化率MIRMMM
| Q1 26 | — | — | ||
| Q4 25 | 4.22× | 2.74× | ||
| Q3 25 | 7.69× | 2.11× | ||
| Q2 25 | 1.49× | -1.32× | ||
| Q1 25 | 118.67× | -0.07× | ||
| Q4 24 | 4.05× | 2.50× | ||
| Q3 24 | — | -1.30× | ||
| Q2 24 | — | 0.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MIR
| Transferred Over Time | $96.6M | 35% |
| Services | $65.0M | 23% |
| Cancer Care | $61.8M | 22% |
| Labs And Research | $34.0M | 12% |
| Other Care | $20.7M | 7% |
MMM
| Safety and Industrial business segment | $2.9B | 49% |
| Transportation and Electronics business segment | $1.8B | 31% |
| Consumer business segment | $1.1B | 19% |
| Corporate | $121.0M | 2% |
